← back to evidence hierarchy
evidence card · metformin_human_lifespan

Metformin extends lifespan in humans without diabetes

H3 ? insufficient stakes moderate
1 post scored · across 1 account · 3 sources

Summary

UKPDS showed CV benefit in T2DM. Observational studies in non-diabetics are confounded. TAME trial was proposed but has not read out. May even blunt exercise mitochondrial gains.

Five-score assessment

Scores not yet assigned for this card. (Legacy card; will be populated on next refinement.)

Scope

Population
adults without diabetes
Intervention
metformin
Outcome
lifespan, all-cause mortality
Not supported for
  • routine use for longevity in non-diabetics

Evidence sources

Account mentions